Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024
However, patients who received initial stimulant prescription via telehealth had increased odds of stimulant use disorder
Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024
However, patients who received initial stimulant prescription via telehealth had increased odds of stimulant use disorder